Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.17799 | 68 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.03057 | 67 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.61143 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.57035 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.72197 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.17664 | 46 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.09807 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.33462 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.57784 | 60 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.76854 | 73 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.9544 | 66 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.27137 | 69 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.6269 | 60 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.02087 | 67 |